Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Naltrexone for Prolonged Grief Disorder
IRCT20250611066174N1Phase 3Completed
- Sponsor
- Zahedan University of Medical Sciences
- Start
- Jul 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of naltrexone in complicated grief disorder (PGD), sponsored by Zahedan University of Medical Sciences. Started Jul 2025; status: completed.
02
Drugs
naltrexone
03
Conditions
complicated grief disorder (PGD)
Beyond the preview
Go deeper on IRCT20250611066174N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20250611066174N1.